Kashaf Tariq

Higher Degree by Research Candidate

School of Pharmacy and Biomedical Sciences

College of Health


I am a PhD candidate in medicine with expertise in the cellular and molecular mechanisms underlying immune-mediated pathology. My research focuses on understanding how our immune systems can recognise and respond to cancer, with a view towards developing new immunotherapies for patients with solid tumours.
I am honoured to be awarded a Commonwealth funded Australian Government Research Training Program (RTP) scholarship to support my PhD research at Adelaide University, Australia.
I was also awarded the ANSO (Alliance of International Science Organizations) scholarship for Young Talents, which supported my postgraduate studies at University of Chinese Academy of Sciences, China.

Language Competency
Chinese (Mandarin) Can speak and understand spoken
English Can read, write, speak, understand spoken and peer review
Urdu Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2025 Adelaide University Australia PhD
2022 - 2025 University of Chinese Academy of Sciences China Master
2018 - 2022 Khwaja Fareed University of Engineering and Information Technology Pakistan Bachelor

Year Citation
2025 Ibrahim, A., Mohamady Farouk Abdalsalam, N., Liang, Z., Kashaf Tariq, H., Li, R., O. Afolabi, L., . . . Yan, D. (2025). MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy. Cancer Gene Therapy, 32(4), 371-392.
DOI
2025 Rabiu, L., Zhang, P., Liu, Z., Tang, Y., Gidado, K. I., Ibrahim, A., . . . Zhang, G. (2025). TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function. Inflammation Research, 74(1).
DOI
- Ashraf, M. A., Tariq, H. K., Hu, X. -W., Khan, J., & Zou, Z. (2022). Computational Biology and Machine Learning Approaches Identify Rubber Tree (Hevea brasiliensis Muell. Arg.) Genome Encoded MicroRNAs Targeting Rubber Tree Virus 1. Applied Sciences, 12(24), 12908.
DOI
- Mohamady Farouk Abdalsalam, N., Liang, Z., Kashaf Tariq, H., Ibrahim, A., Li, R., Wan, X., & Yan, D. (2024). Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy. Biology, 13(11), 949.
DOI
- Tariq, H. K., Liang, Z., Rabiu, L., Ibrahim, A., Mohamady Farouk Abdalsalam, N., Li, R., . . . Yan, D. (2025). Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy. Cells, 14(2), 108.
DOI

Connect With Me

External Profiles

Other Links